Health Canada has approved Pfizer's antiviral treatment for COVID-19, which can help prevent high-risk people from ending up in the hospital. But extremely limited supplies mean provinces and territories must prioritize the treatment for people at most risk of serious illness, including severely immune-compromised patients and some unvaccinated people over the age of 60.